MECLIZINE HYDROCHLORIDE description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

MECLIZINE HYDROCHLORIDE

REMEDYREPACK INC.

MECLIZINE HYDROCHLORIDE TABLETS, USPRx only


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

MECLIZINE HYDROCHLORIDE DESCRIPTION

Chemically, Meclizine HCl is 1-(p-chloro-α-phenylbenzyl)-4-(m-methylbenzyl) piperazine dihydrochloride monohydrate.

MECLIZINE HYDROCHLORIDE

                          C25H27ClN2 . 2HCl. H2O                                                                                        M.W. 481.88

Meclizine HCI Tablets, USP are available in two different strengths: 12.5 mg and 25 mg. In addition each tablet contains the following inactive ingredients: Colloidal Silicon Dioxide, Croscarmellose Sodium, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose. Also, Meclizine HCI Tablets USP, 12.5 mg contains FD&C Blue #1 Aluminum Lake (11-13%) and Meclizine HCI Tablets USP, 25 mg contains D&C Yellow #10 Aluminum Lake (15-20%).

 

CLINICAL PHARMACOLOGY

Meclizine Hydrochloride is an antihistamine which shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum.

 

INDICATIONS & USAGE

For the management of nausea and vomiting, and dizziness associated with motion sickness.

 

MECLIZINE HYDROCHLORIDE CONTRAINDICATIONS

Meclizine Hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it.

 

WARNINGS

Since drowsiness may, on occasion, occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery.

Patients should avoid alcoholic beverages while taking this drug.

Due to its potential anticholinergic action, this drug should be used with caution in patients with asthma, glaucoma or enlargement of the prostate gland.

 

PRECAUTIONS

PREGNANCY, Teratogenic Effects
Pregnancy Category B. Reproduction studies in rats have shown cleft palates at 25-50 times the human dose. Epidemiological studies in pregnant women, however, do not indicate that medicine increases the risk of abnormalities when administered during pregnancy. Despite the animal findings, it would appear that the possibility of fetal harm is remote. Nevertheless, meclizine, or any other medication, should be used during pregnancy only if clearly necessary. 

Pediatric Use
Clinical studies establishing safety and effectiveness in children have not been done; therefore, usage is not recommended in children under 12 years of age.

 

MECLIZINE HYDROCHLORIDE ADVERSE REACTIONS

Drowsiness, dry mouth and, on rare occasions, blurred vision have been reported.

 

DOSAGE & ADMINISTRATION

Motion Sickness
The initial dose of 25 to 50 mg of Meclizine HCI should be taken one hour prior to travel for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

 

HOW SUPPLIED

Meclizine HCI Tablets, USP are available in the following strengths and package sizes:

12.5 mg (Blue, oval-shaped, scored, debossed with TL122)

Bottles of 100           NDC 59746-122-06
Bottles of 1000         NDC 59746-122-10

25 mg (Yellow, oval-shaped, scored, debossed with TL121)

Bottles of 100            NDC 59746-121-06
Bottles of 1000          NDC 59746-121-10

Store at 20-25°C (68-77°F) (See USP Controlled Room Temperature].

Manufactured By:

Jubilant Cadista Pharmaceuticals Inc.
Salisbury, MD 21801, USA.

Revised 03/11

 

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION

DRUG: MECLIZINE HYDROCHLORIDE


GENERIC: Meclizine Hydrocloride


DOSAGE: TABLET


ADMINSTRATION: ORAL


NDC: 52125-578-20


ACTIVE INGREDIENT(S):

  • Meclizine Hydrochloride 25mg in 1


INACTIVE INGREDIENT(S):

  • Aluminum Oxide
  • Cellulose, Microcrystalline
  • D&c Yellow No. 10
  • Magnesium Stearate
  • Croscarmellose Sodium
  • Lactose Monohydrate
  • Silicon Dioxide


COLOR: yellow


SHAPE: OVAL


SCORE: Two even pieces


SIZE: 13 mm


IMPRINT: TL121


PACKAGING: 100 in 1 VIAL



MECLIZINE HYDROCHLORIDE

MECLIZINE HYDROCHLORIDE

MECLIZINE HYDROCHLORIDE

Meclizine Hydrocloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:52125-578(NDC:59746-121)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
MECLIZINE HYDROCHLORIDE MECLIZINE 25 mg

Inactive Ingredients

Ingredient Name Strength
ALUMINUM OXIDE
cellulose, microcrystalline
D&C YELLOW NO. 10
MAGNESIUM STEARATE
CROSCARMELLOSE SODIUM
lactose monohydrate
SILICON DIOXIDE

Product Characteristics

Color Size Imprint Code Shape
yellow 13 mm TL121 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:52125-578-20 100 in 1 VIAL

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040659 2013-05-24


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.